Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelopeprotein of which mediates oncogenic transformation
Sk. Rai et al., Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelopeprotein of which mediates oncogenic transformation, P NAS US, 98(8), 2001, pp. 4443-4448
Citations number
27
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Jaagsiekte sheep retrovirus (JSRV) can induce rapid, multifocal lung cancer
, but JSRV is a simple retrovirus having no known oncogenes. Here we show t
hat the envelope (env) gene of JSRV has the unusual property that it can in
duce transformation in rat fibroblasts, and thus is likely to be responsibl
e for oncogenesis in animals. Retrovirus entry into cells is mediated by En
v interaction with particular cell-surface receptors, and we have used phen
otypic screening of radiation hybrid cell lines to identify the candidate l
ung cancer tumor suppressor HYAL2/LUCA2 as the receptor for JSRV. HYAL2 was
previously described as a lysosomal hyaluronidase, but we show that HYAL2
is actually a glycosylphosphatidylinositol (CPI)-anchored cell-surface prot
ein. Furthermore, we could not detect hyaluronidase activity associated wit
h or secreted by cells expressing HYAL2, whereas we could easily detect suc
h activity from cells expressing the related serum hyaluronidase HYAL1. Alt
hough the function of HYAL2 is currently unknown, other GPI-anchored protei
ns are involved in signal transduction, and some mediate mitogenic response
s, suggesting a potential role of HYAL2 in JSRV Env-mediated oncogenesis. L
ung cancer induced by JSRV closely resembles human bronchiolo-alveolar carc
inoma, a disease that is increasing in frequency and now accounts for appro
ximate to 25% of all lung cancer. The finding that JSRV env is oncogenic an
d the identification of HYAL2 as the JSRV receptor provide tools for furthe
r investigation of the mechanism of JSRV oncogenesis and its relationship t
o human bronchiolo-alveolar carcinoma.